Chairs:
Christopher Schofield (University of Oxford, UK)
Darcey Black (Schering-Plough Corporation, UK)
Registration with tea/coffee
Christopher Schofield (University of Oxford, UK)
Inhibitors for enzymes involved in epigenetic modifications
Arasu Ganesan (University of Southampton, UK)
Recent advances in mass spectrometry and application to epigenetics
Benedikt Kessler (Nuffield Department of Clinical Medicine, Oxford, UK)
Epigenetic mechanisms in human disease
Moshe Szyf (McGill University, Canada)
Advances in CHIP-seq and next generation sequencing
Peter J Park (Harvard University, USA)
Lysine methylation as epigenetic mechanism
Rob Klose (Department of Biochemistry, University of Oxford, UK)
Chemical probes for epigenetic signalling
Udo Oppermann (Structural Genomics Consortium, Oxford, UK)